Publicaciones en las que colabora con Francisco Otero Espinar (79)

2021

  1. Development and characterization of a tacrolimus/ hydroxypropyl-β-cyclodextrin eye drop

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-27

  2. Diseño, desarrollo y caracterización de nanopartículas de PLGA cargadas con adalimumab

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 63-65

  3. Indomethacin microencapsulation in polymeric blends of PLGA502 and PEOT-PBT multiblock copolymer

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 57-59

2019

  1. Development, characterization, and in vitro evaluation of resveratrol-loaded poly-(ε-caprolactone) microcapsules prepared by ultrasonic atomization for intra-articular administration

    Pharmaceutics, Vol. 11, Núm. 6

  2. Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model

    International Journal of Pharmaceutics, Vol. 572

  3. Three-Dimensional Hybrid Mesoporous Scaffolds for Simvastatin Sustained Delivery with in Vitro Cell Compatibility

    ACS Omega, Vol. 4, Núm. 3, pp. 5496-5508

2018

  1. Ophthalmic Econazole Hydrogels for the Treatment of Fungal Keratitis

    Journal of Pharmaceutical Sciences, Vol. 107, Núm. 5, pp. 1342-1351

  2. Stimuli sensitive ocular drug delivery systems

    Drug Targeting and Stimuli Sensitive Drug Delivery Systems (Elsevier), pp. 211-270

2017

  1. Cellulose-polysaccharide film-coating of cyclodextrin based pellets for controlled drug release

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 273-283

  2. Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis

    Farmacia Hospitalaria, Vol. 41, Núm. 6, pp. 678-687

  3. Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging

    International Journal of Pharmaceutics, Vol. 528, Núm. 1-2, pp. 714-722

  4. Development and characterization of anti-inflammatory activity of curcumin-loaded biodegradable microspheres with potential use in intestinal inflammatory disorders

    International Journal of Pharmaceutics, Vol. 518, Núm. 1-2, pp. 86-104

  5. In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 317-323

  6. Pharmacokinetic model of florfenicol in turbot (Scophthalmus maximus): establishment of optimal dosage and administration in medicated feed

    Journal of Fish Diseases, Vol. 40, Núm. 3, pp. 411-424

  7. Positron emission tomography for the development and characterization of corneal permanence of ophthalmic pharmaceutical formulations

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 772-780

  8. Preclinical PET study of intravitreal injections

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 7, pp. 2843-2851

2016

  1. Evaluation of the in vitro ocular toxicity of the fortified antibiotic eye drops prepared at the hospital pharmacy departments

    Farmacia Hospitalaria, Vol. 40, Núm. 5, pp. 352-370

  2. La optimización de las formulaciones magistrales oftálmicas en los servicios de farmacia hospitalaria

    El Farmacéutico. Hospitales, Núm. 207, pp. 4-14

  3. Ophthalmic formulations new goals

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

2015

  1. In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 94, pp. 342-351